Trial Details
COMPLETEDBasic Information
| Clinical ID | c4279 |
|---|---|
| Identifier | NCT00746447 |
| Trial Title | Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative|Recurrence |
| Interventions | DRUG: mesalamine granules|DRUG: mesalamine granules|DRUG: mesalamine granules |
Participant Information
| Sponsor | Dr. Falk Pharma GmbH |
|---|---|
| City | Cologne |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2005-05 |
|---|---|
| Primary Completion Date | 2007-04 |
| Completion Date | 2008-03 |